Yıl: 2022 Cilt: 28 Sayı: 1 Sayfa Aralığı: 8 - 13 Metin Dili: İngilizce DOI: 10.4274/vhd.galenos.2021.2021-7-1 İndeks Tarihi: 10-05-2023

Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?

Öz:
Objectives: If not treated early, morbidity and mortality will remain high in hepatitis B virus infection. In this study, it was aimed to analyze the liver biopsy results of patients with chronic hepatitis B with normal alanine aminotransferase (ALT) levels. Materials and Methods: The study was conducted retrospectively. The patients who were admitted in the infectious diseases and clinical microbiology outpatient clinic, had liver biopsy and received treatment between 01.09.2019 and 01.12.2019, were included. Results: A total of 169 patients were included in the study. Of the individuals, 95 (56.2%) were female, with a mean age of 42.4±11.15 years. The rates of having an histological activity index (HAI) score of 6/18 and above and a fibrosis stage of 2/6 or more (90%, 100%, respectively) in patients with ALT level above upper limit of normal (ULN) were higher than in patients with ALT level belowULN (63.6% and 79.1%, respectively) (p=0.001 and p=0.002, respectively). When 129 patients with ALT level below ULN were evaluated in subgroup analyses. HAI score was 6 or higher in 59 (58.4%) of the hepatitis B e antigen (HBeAg) negative patients, and fibrosis stage was 2 or higher in 76 (75.2%) patients. In patients with ALT below ULN and HBeAg positivity, the rates of HAI score of 6 and above and fibrosis stage of 2 and above were found to be statistically significantly higher than in HBeAg negative patients. Conclusion: Liver fibrosis and necroinflammation may develop in patients with normal ALT levels. In making the biopsy decision, ALT level should be considered together with other factors that may affect liver damage.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH; American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261- 283.
  • Chen DS, Locarnini S, Wait S, Bae SH, Chen PJ, Fung JY, Kim HS, Lu SN, Sung J, Tanaka J, Wakita T, Ward J, Wallace J; CEVHAP North Asia Workshop on Viral Hepatitis. Report from a Viral Hepatitis Policy Forum on implementing the WHO Framework for Global Action on viral hepatitis in North Asia. J Hepatol. 2013;59:1073-1080.
  • Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, Bernstien D, Maruyama H, Saraswat V, Chawla Y, Hamid S, Abbas Z, Bedossa P, Sakhuja P, Elmahatab M, Lim SG, Lesmana L, Sollano J, Jia JD, Abbas B, Omar A, Sharma B, Payawal D, Abdallah A, Serwah A, Hamed A, Elsayed A, AbdelMaqsod A, Hassanein T, Ihab A, GHaziuan H, Zein N, Kumar M. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1-30.
  • Turkish Liver Research Association and Viral Hepatitis Combating Association. Turkey Viral Hepatitis Diagnosis and Treatment Guidelines. 2017. https://www.vhsd.org/tr/article/desc/48317/tu-rkiye-viral- hepatitler-tani-ve-tedavi-kilavuzu-2-7.html
  • Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken). 2018;12:33-34.
  • European Association for the Study of the Liver. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67:370-398.
  • Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
  • Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112:18-35.
  • Lai M, Hyatt BJ, Nasser I, Curry M, Afdhal NH. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760-767.
  • Papatheodoridis GV, Manolakopoulos S, Liaw YF, Lok A. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol. 2012;57:196-202.
  • Park JY, Park YN, Kim DY, Paik YH, Lee KS, Moon BS, Han KH, Chon CY, Ahn SH. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. J Viral Hepat. 2008;15:615-621.
  • LiaoB,WangZ,LinS,XuY,YiJ,XuM,HuangZ,ZhouY,ZhangF,Hou J. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT. PLoS One. 2013;8:e78672.
  • Moreno-Cubero E, Arco RTSD, Peña-Asensio J, Villalobos ES, Míquel J, Larrubia JR. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? World J Gastroenterol. 2018;24:1825- 1838.
  • Abdo AA, Bzeizi KI, Babatin MA, AlSohaibani F, AlMana H, Alsaad KO, AlGhamdiH,Al-HamoudiW,AlSwatK,AlFalehFZ,MyersRP,SanaiFM. Predictors of significant fibrosis in chronic hepatitis B patients with low viremia. J Clin Gastroenterol. 2014;48:e50-e56.
  • Chen EQ, Huang FJ, He LL, Bai L, Wang LC, Zhou TY, Lei XZ, Liu C, Tang H. Histological changes in chinese chronic hepatitis B patients with ALT lower than two times upper limits of normal. Dig Dis Sci. 2010;55:432-437.
  • Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL. A treatment algorithm for the management of chronic hepatitis B virüs infection in the United States: an update. Clin Gastroenterol Hepatol. 2006;4:936-962.
  • Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S. Virologic and Histological Features of Chronic Hepatitis B Virus-Infected Asymptomatic Patients with Persistently Normal ALT. Gastroenterology. 2008;134:1376-1384.
  • Tsang PS, Trinh H, Garcia RT, Phan JT, Ha NB, Nguyen H, Nguyen K, Keeffe EB, Nguyen MH. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine amino transferase levels. Clin Gastroenterol Hepatol. 2008;6:569-574.
  • Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
  • Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678- 686.
  • Degertekin B, Tozun N, Demir F, Soylemez G, Yapali S, Bozkurt U, Gurtay E, Seymenoglu TH, Mutlu D, Toraman M. Determination of the upper limits of normal serum alanine aminotransferase (ALT) level in healthy Turkish population. Hepatology Forum. 2020;2:44-47.
APA YILDIZ I, Bahçeci İ, Ilgar T, Çeliker M, kostakoglu u, erturk a (2022). Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. , 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
Chicago YILDIZ ILKNUR ESEN,Bahçeci İlkay,Ilgar Tuba,Çeliker Metin,kostakoglu ugur,erturk ayse Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. (2022): 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
MLA YILDIZ ILKNUR ESEN,Bahçeci İlkay,Ilgar Tuba,Çeliker Metin,kostakoglu ugur,erturk ayse Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. , 2022, ss.8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
AMA YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. . 2022; 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
Vancouver YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. . 2022; 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
IEEE YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a "Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?." , ss.8 - 13, 2022. 10.4274/vhd.galenos.2021.2021-7-1
ISNAD YILDIZ, ILKNUR ESEN vd. "Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?". (2022), 8-13. https://doi.org/10.4274/vhd.galenos.2021.2021-7-1
APA YILDIZ I, Bahçeci İ, Ilgar T, Çeliker M, kostakoglu u, erturk a (2022). Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. Viral Hepatitis Journal, 28(1), 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
Chicago YILDIZ ILKNUR ESEN,Bahçeci İlkay,Ilgar Tuba,Çeliker Metin,kostakoglu ugur,erturk ayse Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. Viral Hepatitis Journal 28, no.1 (2022): 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
MLA YILDIZ ILKNUR ESEN,Bahçeci İlkay,Ilgar Tuba,Çeliker Metin,kostakoglu ugur,erturk ayse Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. Viral Hepatitis Journal, vol.28, no.1, 2022, ss.8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
AMA YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. Viral Hepatitis Journal. 2022; 28(1): 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
Vancouver YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?. Viral Hepatitis Journal. 2022; 28(1): 8 - 13. 10.4274/vhd.galenos.2021.2021-7-1
IEEE YILDIZ I,Bahçeci İ,Ilgar T,Çeliker M,kostakoglu u,erturk a "Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?." Viral Hepatitis Journal, 28, ss.8 - 13, 2022. 10.4274/vhd.galenos.2021.2021-7-1
ISNAD YILDIZ, ILKNUR ESEN vd. "Is Liver Biopsy Necessary in Patients with Chronic Hepatitis B with Normal Alanine Aminotransferase Level?". Viral Hepatitis Journal 28/1 (2022), 8-13. https://doi.org/10.4274/vhd.galenos.2021.2021-7-1